CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Appropriations History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Appropriations | ₹26,711 Cr | ₹22,179 Cr | ₹18,471 Cr | ₹16,054 Cr | ₹13,523 Cr |
What is the latest Appropriations of CIPLA ?
| Year | Appropriations |
|---|---|
| Mar2026 | ₹26,711 Cr |
| Mar2025 | ₹22,179 Cr |
| Mar2024 | ₹18,471 Cr |
| Mar2023 | ₹16,054 Cr |
| Mar2022 | ₹13,523 Cr |
How is Appropriations of CIPLA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2026 | ₹26,711 Cr | 20.44 | |
| Mar2025 | ₹22,179 Cr | 20.07 | |
| Mar2024 | ₹18,471 Cr | 15.06 | |
| Mar2023 | ₹16,054 Cr | 18.72 | |
| Mar2022 | ₹13,523 Cr | - | |
Compare Appropriations of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹113,990.7 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| MANKIND PHARMA | ₹106,446.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.4% |
8.1% |
-6.8% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses